Complexation of Nifedipine with Substituted Phenolic Ligands
- 1 January 1988
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 05 (10) , 655-659
- https://doi.org/10.1023/a:1015979021590
Abstract
The bioavailability of nifedipine in man is highly variable. This may be partly due to its poor aqueous solubility (5–6 µg/ml over pH 2.2–10.0, as determined in this laboratory). We initiated this study to examine the enhancement of aqueous nifedipine solubility via complexation. A series of substituted aromatic ligands was studied to identify those structural features important for complexation with nifedipine. The studies were performed at 25°C employing the solubility technique, using pH 2.2 or 7.0 buffers at an ionic strength of 0.25 M. The apparent equilibrium complexation constants for the 1:1 and/or 1:2 complexes were determined, where appropriate. A linear free-energy approach was used to relate K1:1 with Hammett's sigma (σ) and fractional partition coefficient (π) parameters. The following correlation was obtained: log (Kl:l/Ko = 0.31σ + 0.l0π + 0.36 (r2 = 0.86, P < 0.003, N = 9), where Ko is the complexation constant for phenol. Statistical analyses showed that σ was more important than π in affecting nifedipine complexation. The exact location of this interaction on the nifedipine molecule is undefined at present.This publication has 13 references indexed in Scilit:
- Quantitative Structure–Stability Relationships Among Inclusion Complexes of Cyclodextrins I: Barbituric Acid DerivativesJournal of Pharmaceutical Sciences, 1985
- Nifedipine: Kinetics and dynamics in healthy subjectsClinical Pharmacology & Therapeutics, 1984
- Measurement of nifedipine in plasma by gas--liquid chromatography and electron-capture detection.Clinical Chemistry, 1983
- Potentiometric Study of Molecular Complexes of Weak Acids and Bases Applied to Complexes of α-Cyclodextrin with para -Substituted Benzoic AcidsJournal of Pharmaceutical Sciences, 1982
- New Direct Calculation of K1:1 and K1:2 Complexation Constants Using Solubility MethodJournal of Pharmaceutical Sciences, 1981
- Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridineJournal of Medicinal Chemistry, 1980
- Rationalization of Drug Complexation in Aqueous Solution by use of Hückel Frontier Molecular OrbitalsJournal of Pharmaceutical Sciences, 1980
- Substituent Constant for Drug Design Studies Based on Properties of Organic Electron Donor–Acceptor ComplexesJournal of Pharmaceutical Sciences, 1978
- Physicochemical-activity relations in practice. 1. Rational and self-consistent data bankJournal of Medicinal Chemistry, 1975
- Complexation of Organic Substances in Aqueous Solution by Hydroxyaromatic Acids and Their Salts II.Journal of Pharmaceutical Sciences, 1964